Page-4 of November 2012 Current Affairs, GK & News

India’s plans to modify ITRs opposed by Civil society and industry

November 29, 2012

International Telecommunications Regulations (ITRs) India’s made a proposal on ITRs and submitted the same to the International Telecommunications Union (ITU) in October, 2012. The proposal has drawn opposition from, and fears of content control among, civil society and the industry. National Association of Software and Services Companies (NASSCOM), Cellular Operators Association of India (COAI), Internet ..

Month: 

Topics:  • • •

Liquid Index ETFs shall be eligible for trading in the SLB segment: SEBI

November 29, 2012

As part of changes in the securities lending and borrowing framework, SEBI has permitted ETFs (Exchange Traded Funds) that track indices to trade in the short selling market. Liquid Index ETFs shall be eligible for trading in the Securities Lending and Borrowing (SLB) segment. SEBI has also said that an Index ETF would be considered ..

Month: 

Topics:  • • •

India successfully test fired supersonic interceptor missile

November 29, 2012

Giving a boost to Ballistic Missile Defence (BMD) capability, India successfully launched an interceptor missile to destroy an incoming target missile in a accurate hit at an altitude of 15 km over the Bay of Bengal. The target missile played as an incoming enemy missile with a range of more than 2,000 km. In the ..

Month: 

Topics:  • •

Security OF D8 leaders a major concern for Pakistan

November 29, 2012

For Pakistan, who is hosting D8 summit, security of the group’s leaders has become a major challenge amid increasing incidents of suicide attacks. What is D8? D8 or Developing 8 is the group of 8 developing nations with large Muslim populations that have formed an economic development alliance. Members: Bangladesh, Egypt, Indonesia, Iran, Malaysia, Nigeria, ..

Month: 

Topics:  • • • • • • • • •

Aurobindo Pharma recalled anti-depressant drug from US

November 27, 2012

Hyderabad based Aurobindo Pharma Ltd recalled Mirtazapine drug from the US market due to the product not meeting a specification for a known degradation product during routine stability testing. The drug is an anti-depressant and generally indicated for treatment of mood disorders.

Month: 

Topics:  • • • • •